Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[68Ga]Ga-DPI-4452 and [177Lu]Lu-DPI-4452 in Advanced Solid Tumors
NCT05706129Phase 2Recruiting
- Sponsor
- Lumara Bio
- Start
- Mar 2023
- Primary completion
- Jun 2027
- Modality
- Peptides, Small Molecules, Antibody-Radionuclide Conjugates
- Countries
- 2
01
Overview
A Phase 2 trial of ITM-91, [68Ga]Ga-DPI-4452 in solid tumor, clear cell renal cell carcinoma (ccRCC), pancreatic ductal adenocarcinoma (PDAC), colorectal cancer (CRC), urothelial carcinoma (UC), sponsored by Lumara Bio. Started Mar 2023; status: recruiting.
02
Drugs
ITM-91[68Ga]Ga-DPI-4452
03
Conditions
solid tumorclear cell renal cell carcinoma (ccRCC)pancreatic ductal adenocarcinoma (PDAC)colorectal cancer (CRC)urothelial carcinoma (UC)
Beyond the preview
Go deeper on NCT05706129.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05706129.